galanin(10-29) (rat/mouse) [3526]
galanin(10-29) (rat/mouse)
| SMILES |
CCC(C)C(NC(=O)C(C)NC(=O)C(Cc1c[nH]cn1)NC(=O)C1CCCN1C(=O)CNC(=O)C(CC(C)C)NC(=O)C(N)CC(C)C)C(=O)NC(CC(=O)O)C(=O)NC(CC(N)=O)C(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCN=C(N)N)C(=O)NC(CO)C(=O)NC(Cc1ccccc1)C(=O)NC(CO)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(Cc1c[nH]cn1)C(=O)NCC(=O)NC(CC(C)C)C(=O)NC(C(=O)O)C(C)O |
| InChIKey |
VPBCUXGDMVBSJJ-UHFFFAOYSA-N |
| Sequence |
LLGPHAIDNHRSFSDKHGLT |
| HELM |
PEPTIDE1{L.L.G.P.H.A.I.D.N.H.R.S.F.S.D.K.H.G.L.T}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
None |
| Hydrogen bond donors |
None |
| Rotatable bonds |
None |
| Log P |
None |
| Molecular weight (Da) |
None |
No bioactivity data available.
galanin(10-29) (rat/mouse)
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.